Crossmark

Confirm presence of metallo-β-lactamase-producing Gram-negative bacteria to inform treatment of infection, although clinical data are limited for current and emerging treatment options

Crossref DOI link: https://doi.org/10.1007/s40267-025-01173-1

Published Online: 2025-08-11

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

McGuigan, Aisling https://orcid.org/0009-0009-7260-8131
License Information

Text and Data Mining valid from 2025-08-11

Version of Record valid from 2025-08-11
More Information

Article History

Accepted: 8 June 2025

First Online: 11 August 2025

Declarations

:

: The preparation of this review was not supported by any external funding.

: A. McGuigan is a salaried employee of Adis International Ltd/Springer Nature and declares no relevant conflicts of interest. All authors contributed to this article and are responsible for its content.

: Not applicable.

Document is current

Any future updates will be listed below